PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: TrovaGene, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Researchers Focus on Novel Test to Detect Lyme Disease - TrovaGene Scientists aiming to solve mystery of accurately diagnosing the disease in bid to help curb the rising number of cases
Researchers Focus on Novel Test to Detect Lyme Disease

 

NewswireToday - /newswire/ - San Diego, CA, United States, 2010/06/02 - TrovaGene Scientists aiming to solve mystery of accurately diagnosing the disease in bid to help curb the rising number of cases. TROV.PK

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

As Lyme disease increases at an alarming pace and fears that undiagnosed cases are creating a medical iceberg, scientists are working with speed and diligence to unlock the secret to a more effective test to head off an even wider medical crisis.

The challenge is to develop a test that is not only quick and accurate, but that is so sensitive that it cannot be fooled into failing to diagnose the illness, or to misdiagnose it as something else.

Scientists at TrovaGene, Inc., (formerly Xenomics, Inc.) a developer of transrenal molecular diagnostics, are now working on a non-invasive, urine-based test to diagnose and monitor various diseases and disorders, and which company officials say can be applied to the corkscrew-shaped bacterium Borrelia burgdorferi, better known as Lyme disease, and if successful, provide the most effective test available.

“We have begun research and expect significant results in 2011,” said Thomas Adams, TrovaGene’s Board Chairman.
"The critical distinction from existing tests is that the TrovaGene technology provides a more highly-sensitive method of detection by finding and analyzing "ultra short" (20-50 base pair) nucleic acids in a urine specimen."
“Looking for these short DNA sequences should result in a highly reliable test for the disease,” said Adams.

The testing involves the collection of a urine sample from the patient, thus eliminating the need for an invasive blood drawing procedure.

Lyme disease, so coined because the initial outbreak, spread by the Deer tick, occurred near the Connecticut river town of Old Lyme. In the latest report by the Centers for Disease Control and Prevention (CDC), 28,921 people were stricken in 2008. But authorities estimate the real number could be 10 times greater because of undiagnosed, misdiagnosed or simply unreported cases.

The symptoms can include headaches, fatigue, joint pain, speech and vision impairment and sleep abnormalities. But accurately diagnosing the disease is another story.

“The disease can be effectively treated with antibiotics if properly diagnosed,” said Adams. “But it has been difficult to diagnose with current testing tools and it can be mistaken for chronic fatigue syndrome, rheumatoid arthritis, multiple sclerosis, Alzheimer's disease, Bell's palsy or even Lou Gehrig's disease (ALS)."
When people do not receive treatment because of non-or-misdiagnosis and the disease lingers in the body, that’s when the condition becomes chronic, Adams said, and the medical agony multiplies.

“We expect that with our urine analysis, results will be available within 24 hours of taking the test,” he added. “We are looking forward to our test providing a substantial breakthrough in the area of Lyme disease detection.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: TrovaGene, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Researchers Focus on Novel Test to Detect Lyme Disease

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Alex Michelini - Trovagene.com 
858-217-4838 x101 bhuebner[.]trovagene.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any TrovaGene, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From TrovaGene, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Rapid Recovery

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)